bioRxivImmunology
Systematic evaluation of intratumoral and peripheral BCR repertoires in three cancers
S. V. Krasik, E. A. Bryushkova, G. V. Sharonov, D. S. Myalik, E. V. Shurganova, D. V. Komarov, I. A. Shagina, P. S. Shpudeiko, M. A. Turchaninova, M. T. Vakhitova, I. V. Samoylenko, D. T. Marinov, L. V. Demidov, V. E. Zagainov, D. M. Chudakov, E. O. Serebrovskaya
Abstract
The current understanding of humoral immune response in cancer patients suggests that tumors may be infiltrated with diffuse B cells of extra-tumoral origin or may develop organized lymphoid structures, where somatic hypermutation and antigen-driven selection occur locally. These processes are believed to be significantly influenced by the tumor microenvironment through secretory factors and biased cell-cell interactions. To explore the manifestation of this influence, we used deep unbiased immunoglobulin profiling and systematically characterized the relationships between B cells in circulation, draining lymph nodes (draining LNs), and tumors in 14 patients with three human cancers. We demonstrated that draining LNs are differentially involved in the interaction with the tumor site, and that significant heterogeneity exists even between different parts of a single lymph node (LN). Next, we confirmed and elaborated upon previous observations regarding intratumoral immunoglobulin heterogeneity. We identified B cell receptor (BCR) clonotypes that were expanded in tumors relative to draining LNs and blood and observed that these tumor-expanded clonotypes were less hypermutated than non-expanded (ubiquitous) clonotypes. Furthermore, we observed a shift in the properties of complementarity-determining region 3 of the BCR heavy chain (CDR-H3) towards less mature and less specific BCR repertoire in tumor-infiltrating B-cells compared to circulating B-cells, which may indicate less stringent control for antibody-producing B cell development in tumor microenvironment (TME). In addition, we found repertoire-level evidence that B-cells may be selected according to their CDR-H3 physicochemical properties before they activate somatic hypermutation (SHM). Altogether, our work outlines a broad picture of the differences in the tumor BCR repertoire relative to non-tumor tissues and points to the unexpected features of the SHM process.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Antibody repertoire analysis of tumor-infiltrating B cells reveals distinct signatures and distributions across tissues
- An atlas of infiltrated B-lymphocytes in breast cancer revealed by paired single-cell RNA-sequencing and antigen receptor profiling
- Capturing the Differences between Humoral Immunity in the Normal and Tumor Environments from Repertoire-Seq of B-Cell Receptors Using Supervised Machine Learning
Hiroki Konishi, Daisuke Komura, … Shumpei Ishikawa·BMC BioinformaticsPeer-reviewed·May 28, 2019
- T-cell receptor sequencing of early stage breast cancer tumors identifies altered clonal structure of the T-cell repertoire
J. F. Beausang, A. J. Wheeler, … S. R. Quake·bioRxiv·Aug 4, 2017
- Multimodal and spatially resolved profiling identifies distinct patterns of T-cell infiltration in nodal B-cell lymphoma entities
T. Roider, M. A. Baertsch, … S. Dietrich·Nature Cell BiologyPeer-reviewed·Mar 1, 2024
- Identification of Tumor-Reactive B Cells and Systemic IgG in Breast Cancer Based on Clonal Frequency in the Sentinel Lymph Node
J. R. McDaniel, S. C. Pero, … D. N. Krag·bioRxiv·Nov 1, 2017